Search Clinical Trials
597,783 trials
ID
Status
Phase
Title
Sponsor
NCT07757672
Salvage Chemotherapy With Sonrotoclax, Cladribine, and Standard-dose Cytarabine, Sequentially Followed by HSCT for R/R AML.Institute of Hematology & Blood Diseases Hospital, ChinaNot Yet RecruitingPhase 1
NCT07757672Not Yet Recruiting
Phase 1
Salvage Chemotherapy With Sonrotoclax, Cladribine, and Standard-dose Cytarabine,...Institute of Hematology &...
NCT07756892
Continuous Monitoring of Body Temperature in Neonates During Therapeutic HypothermiaMedical University of GrazNot Yet Recruiting
NCT07756892Not Yet Recruiting
—
Continuous Monitoring of Body Temperature in Neonates During Therapeutic Hypothe...Medical University of Gra...
NCT07756762
Feasibility of Pre-Conditioning FRT in SarcopeniaUniversity of HullNot Yet RecruitingNot Applicable
NCT07756762Not Yet Recruiting
Not Applicable
Feasibility of Pre-Conditioning FRT in SarcopeniaUniversity of Hull
NCT07758023
Achieving Optimal Medical Therapy Through Percutaneous Treatment of Secondary Mitral Regurgitation to Improve Outcome in Patients With HFrEFAbbottNot Yet RecruitingNot Applicable
NCT07758023Not Yet Recruiting
Not Applicable
Achieving Optimal Medical Therapy Through Percutaneous Treatment of Secondary Mi...Abbott
NCT07758738
Primary Care Screening and Intervention for Patients With Dementia and CaregiversNational Institute on Aging (NIA)Not Yet RecruitingNot Applicable
NCT07758738Not Yet Recruiting
Not Applicable
Primary Care Screening and Intervention for Patients With Dementia and Caregiver...National Institute on Agi...
NCT07757412
Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion in Participants With Relapsed or Refractory Multiple Myeloma.Odense University HospitalNot Yet RecruitingPhase 2
NCT07757412Not Yet Recruiting
Phase 2
Teclistamab in Combination With Pomalidomide Administered in Alternative Fashion...Odense University Hospita...
NCT07758062
Levetiracetam Extended-Release Plus Stupp Protocol for Hypoxic IDH-Wildtype GlioblastomaTianjin Medical University General HospitalNot Yet RecruitingPhase 2
NCT07758062Not Yet Recruiting
Phase 2
Levetiracetam Extended-Release Plus Stupp Protocol for Hypoxic IDH-Wildtype Glio...Tianjin Medical Universit...
NCT07758816
Advancing Integrated Therapies for Gaucher DiseaseSanofi-Yale External Research CollaborationRecruiting
NCT07758816Recruiting
—
Advancing Integrated Therapies for Gaucher DiseaseSanofi-Yale External Rese...
NCT07757607
A Prospective, Multicenter, Single-Arm Study to Support the Clinical Evidence Base for MRace as a Treatment Option for FMR Patients With Complex M-TEER Anatomies (FR)Polares Medical SANot Yet RecruitingNot Applicable
NCT07757607Not Yet Recruiting
Not Applicable
A Prospective, Multicenter, Single-Arm Study to Support the Clinical Evidence Ba...Polares Medical SA
NCT07758244
The Effects of Intradialytic Aerobic Exercise on Clinical Parameters, Coping With Illness, Perceived Benefits of Exercise and Barriers to Exercise in Haemodialysis Patients: A Randomised Controlled TrialMuş Alparslan UniversityNot Yet RecruitingNot Applicable
NCT07758244Not Yet Recruiting
Not Applicable
The Effects of Intradialytic Aerobic Exercise on Clinical Parameters, Coping Wit...Muş Alparslan University
NCT07758166
The First-Night Effect and Sex Differences in Strength and Muscular Endurance PerformanceUniversity of AlcalaCompletedNot Applicable
NCT07758166Completed
Not Applicable
The First-Night Effect and Sex Differences in Strength and Muscular Endurance Pe...University of Alcala
NCT07757724
Chinese Herbal Sachet Therapy for Sleep Quality in Menopausal WomenMacao Polytechnic UniversityCompletedNot Applicable
NCT07757724Completed
Not Applicable
Chinese Herbal Sachet Therapy for Sleep Quality in Menopausal WomenMacao Polytechnic Univers...
NCT07757074
A Comparative Study of Delayed Endoscopic DTI and Latissimus Dorsi ±Impalnt Reconstruction Post-MastectomyDu ZhengguiNot Yet Recruiting
NCT07757074Not Yet Recruiting
—
A Comparative Study of Delayed Endoscopic DTI and Latissimus Dorsi ±Impalnt Reco...Du Zhenggui
NCT07758660
Alzheimer's Disease Research Center (ADRC) PET Component StudyNational Institute on Aging (NIA)Enrolling By InvitationPhase 2
NCT07758660Enrolling By Invitation
Phase 2
Alzheimer's Disease Research Center (ADRC) PET Component StudyNational Institute on Agi...
NCT07757945
Acute Effects of Focal Vibration on Posterior Shoulder Tightness and Tissue Stiffness in Overhead AthletesSaglik Bilimleri UniversitesiActive Not RecruitingNot Applicable
NCT07757945Active Not Recruiting
Not Applicable
Acute Effects of Focal Vibration on Posterior Shoulder Tightness and Tissue Stif...Saglik Bilimleri Universi...
NCT07759011
Clinical Study of Spectral CT VeridaPhilips Clinical & Medical Affairs GlobalNot Yet RecruitingNot Applicable
NCT07759011Not Yet Recruiting
Not Applicable
Clinical Study of Spectral CT VeridaPhilips Clinical & Medica...
NCT07757451
A Prospective, Multicenter,Single-arm Study of DuoCor 2 Ventricular Assist System for the Treatment of Advanced Biventricular Heart FailureShenzhen Core Medical Technology CO.,LTD.Not Yet RecruitingNot Applicable
NCT07757451Not Yet Recruiting
Not Applicable
A Prospective, Multicenter,Single-arm Study of DuoCor 2 Ventricular Assist Syste...Shenzhen Core Medical Tec...
NCT07758608
Renal Impairment Pharmacokinetics (PK) Trial of AfabicinDebiopharm International SANot Yet RecruitingPhase 1
NCT07758608Not Yet Recruiting
Phase 1
Renal Impairment Pharmacokinetics (PK) Trial of AfabicinDebiopharm International...
NCT07757230
A Phase II Study of SSGJ-612 Plus a HER2-Targeted ADC in HR-Positive, HER2-Low or HER2-Ultralow Expression Metastatic Breast CancerShenyang Sunshine Pharmaceutical Co., LTD.Not Yet RecruitingPhase 2
NCT07757230Not Yet Recruiting
Phase 2
A Phase II Study of SSGJ-612 Plus a HER2-Targeted ADC in HR-Positive, HER2-Low o...Shenyang Sunshine Pharmac...
Result Breakdown
Not yet recruiting14 (70%)
Completed2 (10%)
Recruiting1 (5%)
Enrolling by invitation1 (5%)
Active, not recruiting1 (5%)
Unknown1 (5%)
not_applicable10 (50%)
Not Specified4 (20%)
Phase 24 (20%)
Phase 12 (10%)